Genicular Nerve Block Added to Femoral Nerve Block for Analgesia After Total Knee Arthroplasty
GNB-FNB
Addition Of Genicular Nerve Block To Femoral Nerve Block Improves Early Postoperative Analgesia After Total Knee Replacement: A Randomized Controlled Trial
1 other identifier
interventional
80
1 country
2
Brief Summary
Total knee arthroplasty (TKA) is a common orthopedic procedure in which effective postoperative pain management is important for early mobilization and rehabilitation. Various regional anesthesia techniques are used as part of multimodal analgesia protocols to improve postoperative pain control. Genicular nerve block has recently been introduced as a potential motor-sparing technique that may enhance postoperative analgesia when used alone or in combination with other regional blocks. The aim of this randomized controlled study is to evaluate whether the addition of ultrasound-guided genicular nerve block to femoral nerve block improves early postoperative analgesia in patients undergoing primary unilateral total knee arthroplasty under combined spinal-epidural anesthesia. A total of 80 patients aged 18-80 years scheduled for elective primary unilateral TKA will be included and randomly assigned to two groups using sealed envelopes. One group will receive femoral nerve block alone (Group F), while the other group will receive femoral nerve block combined with genicular nerve block (Group FG). Postoperative pain scores using the visual analog scale (VAS), epidural patient-controlled analgesia consumption during the first 24 hours, and the time to additional analgesic requirement will be recorded and compared between the groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2021
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2022
CompletedFirst Submitted
Initial submission to the registry
March 8, 2026
CompletedFirst Posted
Study publicly available on registry
March 18, 2026
CompletedMarch 25, 2026
March 1, 2026
Same day
March 8, 2026
March 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Title: 24-hour postoperative epidural analgesic consumption.Description: The total dose (in ml) of epidural analgesic consumed by the patient via the patient-controlled analgesia (PCA) device within the first 24 hours following total knee arthroplasty su
Total volume (in ml) of the epidural analgesic solution (fentanyl and bupivacaine) consumed by the patient via the patient-controlled analgesia (PCA) device within the first 24 hours post-surgery.
First 24 hours following the total knee arthroplasty (TKA) procedure
24-hour postoperative epidural analgesic consumption.
Total volume (in ml) of epidural analgesic solution (fentanyl and bupivacaine) consumed by the patient via the patient-controlled analgesia (PCA) device within the first 24 hours post-surgery
First 24 hours following the total knee arthroplasty (TKA) procedure.
Study Arms (2)
Group F (Femoral Block Only)
ACTIVE COMPARATORPatients in this group received an ultrasound-guided femoral nerve block administered with 20 ml of 0.25% bupivacaine. All patients also received standardized multimodal analgesia, including epidural patient-controlled analgesia (PCA)
Group FG (Combined Block)
EXPERIMENTALPatients in this group received a combination of an ultrasound-guided femoral nerve block (20 ml of 0.25% bupivacaine) and an ultrasound-guided genicular nerve block. The genicular nerve block targeted the superomedial, superolateral, inferomedial, and inferolateral genicular nerves, with 5 ml of 0.25% bupivacaine administered at each site. All patients also received standardized multimodal analgesia, including epidural patient-controlled analgesia (PCA).
Interventions
Administration of 20 ml of 0.25% bupivacaine to the femoral nerve under ultrasound guidance. This procedure was performed on patients in both Group F and Group FG
Administration of 5 ml of 0.25% bupivacaine to each of the four genicular nerve branches (superomedial, superolateral, inferomedial, and inferolateral) under ultrasound guidance. This procedure was performed only on patients in Group FG
Eligibility Criteria
You may qualify if:
- Patients aged ≥18 years
- Scheduled for elective total knee replacement surgery
- American Society of Anesthesiologists (ASA) physical status I-III
- Planned to receive femoral nerve block with or without genicular nerve block
- Ability to provide written informed consent
You may not qualify if:
- Refusal to participate
- Contraindication to regional anesthesia
- Coagulopathy or ongoing anticoagulant therapy incompatible with nerve block
- Infection at the injection site
- Known allergy to local anesthetics
- Severe hepatic or renal insufficiency
- Cognitive impairment preventing pain assessment
- Chronic opioid use or opioid dependency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Ankara Bilkent City Hospital
Etimesgut, Ankara, 06790, Turkey (Türkiye)
Ankara Bilkent City Hospital
Ankara, Turkey, Turkey (Türkiye)
Related Publications (13)
Luo D, Fan Z, Yin W. Chronic post-surgical pain after total knee arthroplasty: a narrative review. Perioper Med (Lond). 2024 Nov 5;13(1):108. doi: 10.1186/s13741-024-00466-9.
PMID: 39501338RESULTLayera S, Aliste J, Bravo D, Saadawi M, Salinas FV, Tran Q. Motor-sparing nerve blocks for total knee replacement: A scoping review. J Clin Anesth. 2021 Feb;68:110076. doi: 10.1016/j.jclinane.2020.110076. Epub 2020 Oct 6.
PMID: 33035871RESULTGrape S, Kirkham KR, Baeriswyl M, Albrecht E. The analgesic efficacy of sciatic nerve block in addition to femoral nerve block in patients undergoing total knee arthroplasty: a systematic review and meta-analysis. Anaesthesia. 2016 Oct;71(10):1198-209. doi: 10.1111/anae.13568. Epub 2016 Jul 29.
PMID: 27469381RESULTRambhia M, Chen A, Kumar AH, Bullock WM, Bolognesi M, Gadsden J. Ultrasound-guided genicular nerve blocks following total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. Reg Anesth Pain Med. 2021 Oct;46(10):862-866. doi: 10.1136/rapm-2021-102667. Epub 2021 Jul 14.
PMID: 34261807RESULTFonkoue L, Behets C, Kouassi JK, Coyette M, Detrembleur C, Thienpont E, Cornu O. Distribution of sensory nerves supplying the knee joint capsule and implications for genicular blockade and radiofrequency ablation: an anatomical study. Surg Radiol Anat. 2019 Dec;41(12):1461-1471. doi: 10.1007/s00276-019-02291-y. Epub 2019 Jul 23.
PMID: 31338537RESULTAkesen S, Akesen B, Atici T, Gurbet A, Ermutlu C, Ozyalcin A. Comparison of efficacy between the genicular nerve block and the popliteal artery and the capsule of the posterior knee (IPACK) block for total knee replacement surgery: A prospective randomized controlled study. Acta Orthop Traumatol Turc. 2021 Mar;55(2):134-140. doi: 10.5152/j.aott.2021.20187.
PMID: 33847575RESULTSinha A, Arora D, Singh S, Das T, Biswas M. Evaluating Analgesic Efficacy of Single Femoral Nerve Block versus Combined Femoral-Sciatic Nerve Block Post Total Knee Arthroplasty. Anesth Essays Res. 2020 Apr-Jun;14(2):326-330. doi: 10.4103/aer.AER_78_20. Epub 2020 Oct 12.
PMID: 33487837RESULTKrishna Prasad GV. Post-operative analgesia techniques after total knee arthroplasty: A narrative review. Saudi J Anaesth. 2020 Jan-Mar;14(1):85-90. doi: 10.4103/sja.SJA_494_19. Epub 2020 Jan 6.
PMID: 31998025RESULTKukreja P, Venter A, Mason L, Kofskey AM, Northern T, Naranje S, Ghanem E, Lawson PA, Kalagara H. Comparison of Genicular Nerve Block in Combination With Adductor Canal Block in Both Primary and Revision Total Knee Arthroplasty: A Retrospective Case Series. Cureus. 2021 Jul 29;13(7):e16712. doi: 10.7759/cureus.16712. eCollection 2021 Jul.
PMID: 34471571RESULTLiu Q, Wang A, Zhang J. The effects of local infiltration anesthesia and femoral nerve block analgesia after total knee arthroplasty: a systematic review and meta-analysis. Ann Transl Med. 2022 Feb;10(4):178. doi: 10.21037/atm-22-286.
PMID: 35280374RESULTFinkel KJ, Takata ET, Panza G, Stuart W, Kainkaryam P, Maffeo-Mitchell CL, Walker A. A Series of Peripheral Nerve Blocks Combined With Spinal Anesthesia Is Associated With Improved Outcomes Following Total Knee Arthroplasty: A Retrospective Study. Cureus. 2025 Apr 25;17(4):e83000. doi: 10.7759/cureus.83000. eCollection 2025 Apr.
PMID: 40416271RESULTLavand'homme PM, Kehlet H, Rawal N, Joshi GP; PROSPECT Working Group of the European Society of Regional Anaesthesia and Pain Therapy (ESRA). Pain management after total knee arthroplasty: PROcedure SPEcific Postoperative Pain ManagemenT recommendations. Eur J Anaesthesiol. 2022 Sep 1;39(9):743-757. doi: 10.1097/EJA.0000000000001691. Epub 2022 Jul 20.
PMID: 35852550RESULTLebleu J, Pauwels A, Poilvache H, Anract P, Belbachir A. Severe Postoperative Pain in Total Knee Arthroplasty Patients: Risk Factors, Insights and Implications for Pain Management via a Digital Health Approach. J Clin Med. 2023 Dec 15;12(24):7695. doi: 10.3390/jcm12247695.
PMID: 38137764RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Semih Baskan, Proffesor
Ankara City Hospital Bilkent
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Based on your source, you should select the roles that were blinded. If only the outcomes assessor or patients were blinded, check the relevant boxes.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 8, 2026
First Posted
March 18, 2026
Study Start
November 1, 2021
Primary Completion
November 1, 2021
Study Completion
February 28, 2022
Last Updated
March 25, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Use this standard window to ensure compliance with medical journal expectations: Start Date: 9 months after publication of the study results. End Date: 36 months after publication of the study results.
- Access Criteria
- De-identified individual participant data (IPD) will be made available to researchers who provide a methodologically sound research proposal. The proposed research must aim to address specific clinical or statistical questions relevant to the study's scope (total knee arthroplasty analgesia). Proposals will be reviewed by the principal investigator to ensure scientific merit. Access will be granted following the signing of a data access agreement and confirmation of institutional ethics committee approval for the secondary analysis. Requests should be directed to the corresponding author via the official institutional email.
he researchers will share de-identified individual participant data (IPD) underlying the results reported in this study, including demographic data (age, gender, BMI) and primary/secondary outcomes (24-hour epidural consumption and VAS scores). Data will be available to researchers who provide a methodologically sound research proposal approved by the principal investigator. Supporting documents, including the Study Protocol, Statistical Analysis Plan (SAP), and Informed Consent Form (ICF), will also be available. Access will be granted starting 9 months after publication and ending 36 months after the publication date. Data sharing is subject to a signed data access agreement and confirmation of institutional ethics committee approval for the requester's secondary analysis. Requests should be directed to the corresponding author.